Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-23-268168
Filing Date
2023-11-01
Accepted
2023-11-01 16:01:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B d576224d8a12b.htm 8-A12B 13257
  Complete submission text file 0001193125-23-268168.txt   14261
Mailing Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016
Business Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-41855 | Film No.: 231368104
SIC: 2836 Biological Products, (No Diagnostic Substances)